This article has been cited by
1Novel Antibiotics for Multidrug-Resistant Gram-Positive Microorganisms
Koulenti, Xu, Mok, Song, Karageorgopoulos, Armaganidis, Lipman, SotiriosTsiodras
Microorganisms.2019;7(8)270
[DOI]
2Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
Leama Ajaka,Emily Heil,Sarah Schmalzle
Antibiotics.2020;9(10)700
[DOI]
3Total Syntheses and Chemical Biology Studies of Hymeglusin and Fusarilactone A, Novel Circumventors of ß-Lactam Drug Resistance in Methicillin-Resistant Staphylococcus aureus
Masahiro Kanaida,Aoi Kimishima,Shuhei Eguchi,Masato Iwatsuki,Yoshihiro Watanabe,Masako Honsho,Tomoyasu Hirose,Yoshihiko Noguchi,Kenichi Nonaka,Goh Sennari,Hidehito Matsui,Chikara Kaito,Hideaki Hanaki,Yukihiro Asami,Toshiaki Sunazuka
ChemMedChem.2021;9(10)700
[DOI]
4Prevention and Treatment of Multidrug-Resistant Organisms in End-Stage Renal Disease
John K. Midturi,Sangeetha Ranganath
Advances in Chronic Kidney Disease.2019;26(1)51
[DOI]
5Antimicrobial activity of dalbavancin and comparators against Staphylococcus aureus causing pneumonia in patients with and without cystic fibrosis
Helio S. Sader,Leonard R. Duncan,Rodrigo E. Mendes
International Journal of Infectious Diseases.2021;107(1)69
[DOI]
6Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion
Urania Rappo,Michael W. Dunne,Sailaja Puttagunta,James S. Baldassarre,Shengfang Su,Daksha Desai-Krieger,Megumi Inoue
Antimicrobial Agents and Chemotherapy.2019;63(11)69
[DOI]
7MODERN APPROACH TO ANTIBACTERIAL THERAPY IN THE PRACTICE OF A SURGEON
A. M. Morozov,A. N. Sergeev,E. M. Askerov,S. V. Zhukov,N. S. Novikova,M. A. Belyak,E. A. Sobol
Bulletin of the Medical Institute "REAVIZ" (REHABILITATION, DOCTOR AND HEALTH).2021;63(11)69
[DOI]
8Emerging antibacterial and antiviral drugs for treating respiratory tract infections
Marco Mantero,Paola Rogliani,Mario Cazzola,Francesco Blasi,Marta Di Pasquale
Expert Opinion on Emerging Drugs.2018;23(3)185
[DOI]
9Mammary Dysbiosis and Nipple Blebs Treated With Intravenous Daptomycin and Dalbavancin
Katrina B. Mitchell,Anne Eglash,Ethan T. Bamberger
Journal of Human Lactation.2020;36(2)365
[DOI]
10Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review
Geren Thomas,Andrés F. Henao-Martínez,Carlos Franco-Paredes,Daniel B. Chastain
International Journal of Antimicrobial Agents.2020;56(3)106069
[DOI]
11Dalbavancin Use in Vulnerable Patients Receiving Outpatient Parenteral Antibiotic Therapy for Invasive Gram-Positive Infections
Jacqueline T. Bork,Emily L. Heil,Shanna Berry,Eurides Lopes,Rohini Davé,Bruce L. Gilliam,Anthony Amoroso
Infectious Diseases and Therapy.2019;8(2)171
[DOI]
12Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
Aaron Hakim,Hannan Braun,David Thornton,Judith Strymish
International Journal of Infectious Diseases.2020;91(2)202
[DOI]
  Feedback 
  Subscribe